Literature DB >> 3955485

Lack of evidence of hepatitis D (delta) infection in Newfoundland and Labrador.

S Ratnam, C B Head, R W Butler.   

Abstract

Epidemiologic knowledge of hepatitis D virus (HDV) infection is limited. A seroepidemiologic study was undertaken to determine the prevalence of the infection in Newfoundland and Labrador. Between October 1983 and October 1985 over 200 people were recognized through routine serodiagnosis and screening as having hepatitis B seromarkers. A total of 223 serum samples from 186 of these people were tested for anti-HDV. The subjects were mainly asymptomatic carriers of hepatitis B surface antigen or patients with acute or chronic hepatitis B from the native Indian and Inuit and the non-native populations. None of the serum samples were positive for anti-HDV. The absence of anti-HDV in a substantial number of people in the province who are infected with hepatitis B virus is strong evidence that HDV infection is not prevalent in the local population, including native people.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3955485      PMCID: PMC1490973     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  17 in total

1.  Epidemiology of delta infection in Scandinavia.

Authors:  B G Hansson; G Norkrans; M Weibull; O Weiland; J Nielsen; P Leinikki; P Ukkonen; O Jensson; J C Siebke
Journal:  Prog Clin Biol Res       Date:  1983

2.  The delta agent.

Authors:  M Rizzetto
Journal:  Hepatology       Date:  1983 Sep-Oct       Impact factor: 17.425

3.  Influence of delta infection on severity of hepatitis B.

Authors:  A Smedile; P Farci; G Verme; F Caredda; A Cargnel; N Caporaso; P Dentico; C Trepo; P Opolon; A Gimson; D Vergani; R Williams; M Rizzetto
Journal:  Lancet       Date:  1982-10-30       Impact factor: 79.321

4.  Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts.

Authors:  G Raimondo; A Smedile; L Gallo; A Balbo; A Ponzetto; M Rizzetto
Journal:  Lancet       Date:  1982-01-30       Impact factor: 79.321

5.  Antibodies to delta antigen in asymptomatic hepatitis B surface antigen-reactive blood donors in the United States and their association with other markers of hepatitis B virus.

Authors:  N Nath; I K Mushahwar; C T Fang; H Berberian; R Y Dodd
Journal:  Am J Epidemiol       Date:  1985-08       Impact factor: 4.897

6.  Delta infection among patients with chronic hepatitis B in the Stockholm region.

Authors:  G Lindh; O Weiland; B G Hansson; A Svedmyr
Journal:  Infection       Date:  1984 Jan-Feb       Impact factor: 3.553

7.  Hepatitis virus infection in an isolated Canadian Inuit (Eskimo) population.

Authors:  G Y Minuk; L E Nicolle; B Postl; J G Waggoner; J H Hoofnagle
Journal:  J Med Virol       Date:  1982       Impact factor: 2.327

8.  Epidemiology of hepatitis B in two Alaska communities.

Authors:  D H Barrett; J M Burks; B McMahon; S Elliott; K R Berquist; T R Bender; J E Maynard
Journal:  Am J Epidemiol       Date:  1977-02       Impact factor: 4.897

9.  Delta virus infection and severe hepatitis. An epidemic in the Yucpa Indians of Venezuela.

Authors:  S C Hadler; M De Monzon; A Ponzetto; E Anzola; D Rivero; A Mondolfi; A Bracho; D P Francis; M A Gerber; S Thung
Journal:  Ann Intern Med       Date:  1984-03       Impact factor: 25.391

10.  Delta infection and liver disease in hemophilic carriers of hepatitis B surface antigen.

Authors:  M Rizzetto; C Morello; P M Mannucci; D J Gocke; J A Spero; J H Lewis; D H Van Thiel; C Scaroni; F Peyretti
Journal:  J Infect Dis       Date:  1982-01       Impact factor: 5.226

View more
  4 in total

1.  Estimation of the secondary attack rate for delta hepatitis coinfection among injection drug users.

Authors:  C Poulin; T Gyorkos; L Joseph
Journal:  Can J Infect Dis       Date:  1993-01

2.  Management of Hepatitis B Virus Infection: 2018 Guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and Infectious Disease Canada.

Authors:  Carla S Coffin; Scott K Fung; Fernando Alvarez; Curtis L Cooper; Karen E Doucette; Claire Fournier; Erin Kelly; Hin Hin Ko; Mang M Ma; Steven R Martin; Carla Osiowy; Alnoor Ramji; Edward Tam; Jean Pierre Villeneuve
Journal:  Can Liver J       Date:  2018-12-25

3.  Chronic hepatitis B infection in Canada.

Authors:  G Y Minuk; J Uhanova
Journal:  Can J Infect Dis       Date:  2001-11

4.  Molecular epidemiology and clinical characteristics of hepatitis D virus infection in Canada.

Authors:  Carla Osiowy; Ken Swidinsky; Sarah Haylock-Jacobs; Matthew D Sadler; Scott Fung; David Wong; Gerald Y Minuk; Karen E Doucette; Philip Wong; Edward Tam; Curtis Cooper; Alnoor Ramji; Mang Ma; Carmine Nudo; Keith Tsoi; Carla S Coffin
Journal:  JHEP Rep       Date:  2022-02-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.